How much does a jin of motherwort seeds cost?

Motherwort, also known as tui, chongwei, kuncao, jiuchonglou, yunmucao, sendi and so on. It is a famous traditional Chinese medicinal herb, and the whole plant can be used as medicine. So how much does a jin of motherwort seeds cost? What about the toxic components of motherwort and the research evidence on its toxicity, and the quality of evidence and future research plans for studies on motherwort injection? Let us take a look together.

1. How much does a jin of motherwort seeds cost

The market price of motherwort seeds has always been very stable, with the price per jin of seeds at around 75 yuan to 90 yuan. This price is still very low and is still within a range that everyone can accept.

2. The toxic components of motherwort and the research evidence on its toxicity

At present, there are relatively few studies on the toxicity of motherwort, especially studies on the toxic side effects of motherwort Chinese patent medicine preparations. It is suggested that further research should be carried out on the material basis, mechanism of action and characteristics of action of the toxic effects of motherwort and its preparations, the dose-response relationship between dosage and toxic effects should be studied, and methods to reduce toxicity in the clinical use of motherwort should be explored, so as to provide an evidence base for setting safe limits for the dosage of motherwort and its preparations, and to provide a reference for their rational and safe clinical use.

3. The quality of evidence and future research plans for studies on motherwort injection

Motherwort injection is an advantageous dosage form among motherwort Chinese patent medicines. Among the included literature, there are only 4 systematic reviews, all of which are studies on motherwort injection for preventing and treating postpartum hemorrhage; there are 133 randomized controlled trials, but the quality of the literature is generally low. Combining the bibliometric curve trend and the current status of clinical application, we believe that there is an urgent need to carry out whole-component analysis under meticulous top-level design for the advantageous dosage forms of motherwort, and to produce high-quality clinical evidence (applicability, effectiveness, safety, economics and their comprehensive evaluation), basic research evidence, translational evidence and economic evidence. At the same time, the drug instructions should be optimized and supplemented according to evidence, and clinical guidelines and clinical pathways should be formulated. In addition, based on high-quality research evidence, advantageous dosage forms and usage and dosage for other new indications of motherwort can be further developed.